Pleasant Prairie, Wis.
Nexus Pharmaceuticals will begin construction in August of 2019 on a $250 million manufacturing complex in Pleasant Prairie, Wis. The multi-phase project will be delivered over the next ten years, enabling Nexus to expand its production capacity for sterile injectable drugs. The first phase comprises an $85 million manufacturing building featuring an advanced isolator system and multiple lyophilization machines. The three-story, 84,450-sf structure was designed by Integrated Project Services and will be built by Turner Construction. Completion is expected by 2021 with commercial production commencing in 2022.
| Organization | Project Role |
|---|---|
|
Integrated Project Services
|
Architect and Engineer
|
|
Turner Construction
|
Construction Manager
|
Source
